SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001567619-20-004317
Filing Date
2020-02-19
Accepted
2020-02-19 17:14:05
Documents
1
Period of Report
2020-02-14

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 4078
  Complete submission text file 0001567619-20-004317.txt   5476
Mailing Address 805 LAS CIMAS PARKWAY SUITE 100 AUSTIN TX 78746
Business Address 805 LAS CIMAS PARKWAY SUITE 100 AUSTIN TX 78746 (512) 942-2935
Aeglea BioTherapeutics, Inc. (Issuer) CIK: 0001636282 (see all company filings)

IRS No.: 464312787 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address C/O AEGLEA BIOTHERAPEUTICS, INC. 901 S. MOPAC EXPRESSWAY, #250 AUSTIN TX 78746
Business Address
Rao Madduri Ravin (Reporting) CIK: 0001792006 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37722 | Film No.: 20631077